Publications (48) MARTINA ALVAREZ PEREZ publications

filter_list

2025

  1. Association of gut microbiota and immune gene expression with response to targeted therapy in BRAF mutated melanoma

    Scientific Reports, Vol. 15, Núm. 1

  2. Author Correction: Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy (Nature, (2019), 569, 7756, (428-432), 10.1038/s41586-019-1162-y)

    Nature

2024

  1. Comparative study of droplet-digital PCR and absolute Q digital PCR for ctDNA detection in early-stage breast cancer patients

    Clinica Chimica Acta, Vol. 552

  2. Exploring the Relationship between MicroRNAs, Intratumoral Microbiota, and Breast Cancer Progression in Patients with and without Metastasis

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

  3. Increased blood draws for ultrasensitive ctDNA and CTCs detection in early breast cancer patients

    npj Breast Cancer, Vol. 10, Núm. 1

  4. Oncogene-addicted solid tumors and microbiome—lung cancer as a main character: a narrative review

    Translational Lung Cancer Research, Vol. 13, Núm. 8, pp. 2050-2066

  5. The Role of Immunohistochemistry as a Surrogate Marker in Molecular Subtyping and Classification of Bladder Cancer

    Diagnostics, Vol. 14, Núm. 22

2023

  1. Development of a Novel NGS Methodology for Ultrasensitive Circulating Tumor DNA Detection as a Tool for Early-Stage Breast Cancer Diagnosis

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

  2. Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma

    Cancers, Vol. 15, Núm. 6

  3. PD-L1 immunoexpression and molecular characterization of histological subtypes in urothelial carcinoma

    Revista Espanola de Patologia, Vol. 56, Núm. 1, pp. 10-20

2022

  1. Association of Circular RNA and Long Non-Coding RNA Dysregulation with the Clinical Response to Immune Checkpoint Blockade in Cutaneous Metastatic Melanoma

    Biomedicines, Vol. 10, Núm. 10

  2. Clinical utility of comprehensive circulating tumor DNA genotyping compared with standard of care tissue testing in patients with newly diagnosed metastatic colorectal cancer

    ESMO Open, Vol. 7, Núm. 3

  3. High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade

    International Journal of Molecular Sciences, Vol. 23, Núm. 16

  4. Laboratory protocol for the digital multiplexed gene expression analysis of nasopharyngeal swab samples using the NanoString nCounter system

    F1000Research, Vol. 11

2020

  1. Ocular surface characterization after allogeneic stem cell transplantation: A prospective study in a referral center

    Indian Journal of Ophthalmology, Vol. 68, Núm. 8, pp. 1556-1562

2019

  1. Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapy

    BMC Cancer, Vol. 19, Núm. 1

  2. Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples

    Scientific Reports, Vol. 9, Núm. 1

  3. Deciphering her2 breast cancer disease: Biological and clinical implications

    Frontiers in Oncology, Vol. 9, Núm. OCT

  4. Detection of TP53 and PIK3CA mutations in circulating tumor DNA using next-generation sequencing in the screening process for early breast cancer diagnosis

    Journal of Clinical Medicine, Vol. 8, Núm. 8

  5. Different Pathological Complete Response Rates According to PAM50 Subtype in HER2+ Breast Cancer Patients Treated With Neoadjuvant Pertuzumab/Trastuzumab vs. Trastuzumab Plus Standard Chemotherapy: An Analysis of Real-World Data

    Frontiers in Oncology, Vol. 9